ADCX-020 for the Treatment of Patients With Locally Advanced or Metastatic Cancers

NCT07238075 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

290

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignancy
Advanced Solid Cancers
Metastatic Solid Tumors

Interventions

DRUG: ADCX-020

Sponsor

Adcytherix SAS